Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL)

Q: What does CUSIP 05280R100 represent in this 13F holders report?

CUSIP 05280R100 is the security identifier for AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share used to aggregate holder disclosures.

Q: How many institutions held AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share in Q1 2020?

50 institutional investors reported AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share for Q1 2020. Use the holders table for investor-level position and value details.

CUSIP: 05280R100

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class: Equity / American Depositary Shares, each representing one ordinary share, par value $0.000042 per share
Shares outstanding: 265,957,447
Total 13F shares: 15,977,491
Share change: +2,568,659
Total reported value: $96,357,056
Price per share: $5.99
Number of holders: 50
Value change: +$6,942,585
Number of buys: 28
Number of sells: 20

Quarterly Holders Quick Answers

What is CUSIP 05280R100?
CUSIP 05280R100 identifies AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2020
Previous quarter: Q4 2019

Recent filing periods for CUSIP 05280R100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Capital World Investors	13F	Company	0.83%	2,195,806	$28,985,000	—	31 Dec 2019	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.79%	2,095,127	$27,656,000	—	31 Dec 2019	13F
Tetragon Partners GP Ltd	13F	Company	0.49%	1,300,000	$17,160,000	—	31 Dec 2019	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.35%	941,500	$12,428,000	—	31 Dec 2019	13F
JUPITER ASSET MANAGEMENT LTD	13F	Company	0.27%	705,356	$9,311,000	—	31 Dec 2019	13F
Alphabet Inc.	13F	Company	0.26%	699,352	$9,231,000	—	31 Dec 2019	13F
MARSHALL WACE, LLP	13F	Company	0.26%	680,181	$8,978,000	—	31 Dec 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.25%	676,481	$8,930,000	—	31 Dec 2019	13F
Capital International Investors	13F	Company	0.25%	674,888	$8,909,000	—	31 Dec 2019	13F
Artal Group S.A.	13F	Company	0.19%	500,000	$6,600,000	—	31 Dec 2019	13F
Cormorant Asset Management, LP	13F	Company	0.18%	479,988	$6,336,000	—	31 Dec 2019	13F
Point72 Asset Management, L.P.	13F	Company	0.12%	315,804	$4,169,000	—	31 Dec 2019	13F
Granahan Investment Management, LLC	13F	Company	0.11%	305,158	$4,028,000	—	31 Dec 2019	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.09%	247,187	$3,263,000	—	31 Dec 2019	13F
BlackRock Finance, Inc.	13F	Company	0.09%	242,510	$3,201,000	—	31 Dec 2019	13F
FMR LLC	13F	Company	0.08%	212,108	$2,800,000	—	31 Dec 2019	13F
Alyeska Investment Group, L.P.	13F	Company	0.08%	207,311	$2,737,000	—	31 Dec 2019	13F
BAKER BROS. ADVISORS LP	13F	Company	0.06%	156,773	$2,069,000	—	31 Dec 2019	13F
Vident Investment Advisory, LLC	13F	Company	0.04%	118,866	$1,569,000	—	31 Dec 2019	13F
DAFNA Capital Management LLC	13F	Company	0.04%	100,000	$1,320,000	—	31 Dec 2019	13F
FEDERATED HERMES, INC.	13F	Company	0.03%	78,168	$1,032,000	—	31 Dec 2019	13F
Bellevue Group AG	13F	Company	0.02%	62,200	$821,000	—	31 Dec 2019	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.02%	50,000	$660,000	—	31 Dec 2019	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.02%	40,700	$537,000	—	31 Dec 2019	13F
MPM BioImpact LLC	13F	Company	0.01%	39,740	$525,000	—	31 Dec 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.01%	38,213	$504,000	—	31 Dec 2019	13F
VIRTUS ADVISERS, LLC	13F	Company	0.01%	32,577	$430,000	—	31 Dec 2019	13F
SG Americas Securities, LLC	13F	Company	0.01%	26,435	$349,000	—	31 Dec 2019	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	23,912	$316,000	—	31 Dec 2019	13F
LADENBURG THALMANN FINANCIAL SERVICES INC.	13F	Company	0.01%	22,500	$297,000	—	31 Dec 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.01%	19,145	$252,000	—	31 Dec 2019	13F
A.R.T. Advisors, LLC	13F	Company	0.01%	17,816	$235,000	—	31 Dec 2019	13F
TD ASSET MANAGEMENT INC	13F	Company	0.01%	17,057	$225,000	—	31 Dec 2019	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.01%	14,373	$190,000	—	31 Dec 2019	13F
Burrage Capital Management LLC	13F	Company	0%	13,113	$173,000	—	31 Dec 2019	13F
STATE STREET CORP	13F	Company	0%	12,708	$168,000	—	31 Dec 2019	13F
BANK OF MONTREAL /CAN/	13F	Company	0%	12,000	$158,000	—	31 Dec 2019	13F
CITADEL ADVISORS LLC	13F	Company	0%	11,541	$152,000	—	31 Dec 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0%	10,716	$141,000	—	31 Dec 2019	13F
Aperio Group, LLC	13F	Company	0%	10,186	$134,000	—	31 Dec 2019	13F
Legal & General Group Plc	13F	Company	0%	3,515	$46,000	—	31 Dec 2019	13F
UBS Group AG	13F	Company	0%	3,233	$43,000	—	31 Dec 2019	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	2,227	$29,000	—	31 Dec 2019	13F
CITIGROUP INC	13F	Company	0%	2,041	$27,000	—	31 Dec 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	1,802	$24,000	—	31 Dec 2019	13F
Marshall Wace North America L.P.	13F	Company	0%	980	$13,000	—	31 Dec 2019	13F
Advisor Group, Inc.	13F	Company	0%	700	$9,000	—	31 Dec 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	672	$9,000	—	31 Dec 2019	13F
PRELUDE CAPITAL MANAGEMENT, LLC	13F	Company	0%	460	$6,000	—	31 Dec 2019	13F
US BANCORP \DE\	13F	Company	0%	242	$3,000	—	31 Dec 2019	13F

Institutional Holders of Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL) as of Q1 2020

As of 31 Mar 2020, Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,977,491 shares. The largest 10 holders included Capital World Investors, SCHRODER INVESTMENT MANAGEMENT GROUP, Polygon Management Ltd., Capital International Investors, MILLENNIUM MANAGEMENT LLC, JUPITER ASSET MANAGEMENT LTD, Alphabet Inc., CITADEL ADVISORS LLC, FRANKLIN RESOURCES INC, and Artal Group S.A.. This page lists 50 institutional shareholders reporting positions in this security for the Q1 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2020 vs Q4 2019 Across Filers

Q4 2019 holders

Q1 2020 holders

Holder diff

-4

Investor	Q4 2019 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q4 2019 Value $	Q1 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.